Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata leads to significantly higher healthcare costs due to more doctor visits and prescriptions.

Local corticosteroids can help with alopecia areata, but hair loss often returns after stopping treatment.

Saw palmetto supplements may modestly improve hair regrowth with few side effects, but more research is needed.

The Alopecia Areata Assessment Tool (ALTO) effectively identifies alopecia areata from other hair loss types but needs more validation.

Middle-aged patients, those in the Northeast, with comprehensive insurance, extensive hair loss, or additional health issues, and young or older females face higher alopecia areata medical costs.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Corticosteroids are the most common treatment for alopecia areata, but many patients need better options.

Patients with alopecia areata prefer treatments that regrow scalp hair quickly over how often they need to take the medication.

Baricitinib helps regrow scalp, eyebrow, and eyelash hair in teens with severe alopecia areata.

Triamcinolone is more effective than methotrexate for treating localized alopecia areata.

Significant, lasting hair regrowth is needed to improve how patients with Alopecia Areata feel about their condition.

Severe alopecia areata patients have a low chance of spontaneous hair regrowth.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

People often have negative attitudes toward those with alopecia, especially if it's severe or seen as a medical issue.

Patients with alopecia areata might have a lower risk of stroke and possibly heart attack.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Patients with alopecia areata feel less regret about treatment decisions when they are involved in the decision-making process.

Most people with alopecia areata stop treatment within a year.

Current treatments for Alopecia Areata are unsatisfactory and need improvement.

The Brigham Eyelash Tool for Alopecia (BELA) is a reliable way to measure eyelash loss in alopecia areata patients.

Isotretinoin may cause hair loss, especially in women and young adults.

Hair regrowth improves quality of life and reduces anxiety and depression in severe alopecia areata patients.

Alopecia areata in US adolescents leads to significant healthcare costs and usage.

Baricitinib is generally safe for long-term use in treating severe alopecia areata.

Regrowing scalp hair improves quality of life and reduces anxiety and depression in severe alopecia areata patients.

Deuruxolitinib significantly helps regrow scalp hair in adults with moderate to severe alopecia areata.

Patients and clinicians generally agree on eyebrow and eyelash hair loss improvements in severe alopecia areata.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.